Nhlbi trans-omics for precision medicine (topmed) for the centralized omics resource (core)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92023D00020
- Awardee
-
University Of Washington UEI HD1WMN6945W6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 4 $9,002,304 obligated
Award facts
- Opportunity
-
- NHLBI Trans-Omics for Precision Medicine (TOPMed) Pre-Solicitation · 75N92022R0108 · Posted May 20, 2022
- Combined order value
-
- $9,002,304 Current, with exercised options
- $17,134,784 Potential, with all options
- Last date to order 31% complete
- IDV ceiling 2% used
- $500,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart Lung and Blood Institute awarded a single-award indefinite-delivery contract to University of Washington on September 13, 2023, with a ceiling value of $500 million for the NHLBI Trans-Omics for Precision Medicine (TopMed) Centralized Omics Resource (CORE) project, with ultimate completion on September 12, 2033.
Work is performed in Seattle, Washington. The IDIQ originated from a May 2022 pre-solicitation requesting capability information for complex data analysis, integration, and management of large-scale genomic and health datasets in support of NHLBI's precision medicine research infrastructure.
The contract runs through September 12, 2033. Three delivery orders have been issued under this IDIQ: the initial DNA methylation analysis order (September 28, 2023, $3.45 million, performance through September 27, 2027); a second DNA methylation analysis delivery order (September 23, 2024, $4.7 million, performance through September 22, 2027); and a centralized omics resource support order (September 23, 2025, $3.85 million, performance through September 22, 2027). All orders are firm fixed price with no set-aside and performance in Seattle, WA. The University of Washington's Office of Sponsored Programs serves as the administrative entity for federal research awards across the institution's research portfolio, competing exclusively in unrestricted full-and-open federal research opportunities.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N92023D00020?
75N92023D00020 was awarded to University Of Washington by National Heart Lung and Blood Institute (National Institutes of Health) on September 13, 2023.
How much is contract 75N92023D00020 worth?
Orders under 75N92023D00020 have obligated $9,002,304. Their combined potential value, with all options, is $17,134,784. 75N92023D00020's own ceiling is $500,000,000.
How many orders have been placed under contract 75N92023D00020?
4 orders have been placed under 75N92023D00020, the latest on September 29, 2026.
Who can order from contract 75N92023D00020?
75N92023D00020 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92023D00020 competed?
The extent of competition for 75N92023D00020 was full and open competition. The government received 13 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV